Cargando…
Modular vaccine platform based on the norovirus-like particle
BACKGROUND: Virus-like particle (VLP) vaccines have recently emerged as a safe and effective alternative to conventional vaccine technologies. The strong immunogenic effects of VLPs can be harnessed for making vaccines against any pathogen by decorating VLPs with antigens from the pathogen. Producin...
Autores principales: | Lampinen, Vili, Heinimäki, Suvi, Laitinen, Olli H., Pesu, Marko, Hankaniemi, Minna M., Blazevic, Vesna, Hytönen, Vesa P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815183/ https://www.ncbi.nlm.nih.gov/pubmed/33468139 http://dx.doi.org/10.1186/s12951-021-00772-0 |
Ejemplares similares
-
SpyTag/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion
por: Lampinen, Vili, et al.
Publicado: (2023) -
Parenterally Administered Norovirus GII.4 Virus-Like Particle Vaccine Formulated with Aluminum Hydroxide or Monophosphoryl Lipid A Adjuvants Induces Systemic but Not Mucosal Immune Responses in Mice
por: Heinimäki, Suvi, et al.
Publicado: (2018) -
Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
por: Tamminen, Kirsi, et al.
Publicado: (2020) -
Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
por: Heinimäki, Suvi, et al.
Publicado: (2020) -
Expression of influenza A virus-derived peptides on a rotavirus VP6-based delivery platform
por: Gröhn, Stina, et al.
Publicado: (2020)